Research and innovation

We are quickly expanding our existence as a leader in patent licensing in the medical gadget, diagnostics and life sciences sectors. .. Acacia subsidiary announces acquisition of 7 medtech patent portfolios Acacia Res...

'The benefit of this manufacturing strategy is that lab-on-a-film microarray creation and assembly can be automated at high speeds, leading to ten to one hundred-fold savings in costs.' If effective, lab-on-a-film man...

APD421, Acacia Pharma's lead item, a D2/D3 antagonist, showed excellent efficacy in its Stage II trial, and had an excellent safety profile. We think that a drug with this novel mechanism and displaying these char...